Portfolio company
Nostos
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Nostos Genomics develops an artificial intelligence platform to provide genetic variant interpretation and disease diagnosis for medical testing laboratories.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Nostos Genomics
The company develops an automated software platform for variant interpretation that helps genetic testing laboratories diagnose patients with rare diseases.
Lucid Genomics
This company develops an artificial intelligence platform for long-read genomic data interpretation to assist clinical laboratories and pharmaceutical researchers with diagnostics.
Qnomx
Qnomx develops an AI platform for molecular diagnostics laboratories to interpret genomic sequencing data and generate clinical reports for precision oncology.
Imagenomix
The company develops an artificial intelligence platform that predicts cancer mutations from pathology images for healthcare providers and biopharma companies.
Genoox
This company develops a cloud-based genomic data analysis platform for clinicians, genetic counsellors, and healthcare organisations to interpret genetic variants and improve patient care.
Genorare
This company develops an encrypted artificial intelligence platform for hospitals and pharmaceutical firms to diagnose rare diseases using genomic and electronic health record data.
FDNA
This company develops artificial intelligence phenotyping software to help clinicians and researchers identify rare diseases and genetic disorders in patients.
Noscendo
This company develops bioinformatic software and diagnostic platforms to identify pathogens in bloodstream infections for hospitals and clinical laboratories.
